CymitQuimica logo

CAS 1224925-76-1

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 produits concernés.
  • Granisetron-d3

    CAS :
    Formule :C18H21D3N4O
    Couleur et forme :White To Off-White Solid
    Masse moléculaire :315.44

    Ref: 4Z-G-071

    5mg
    À demander
    10mg
    1.092,00€
    25mg
    1.942,00€
    50mg
    3.034,00€
    100mg
    À demander
  • Granisetron-d3

    Produit contrôlé
    CAS :

    Applications Granisetron-d3 is the labeled analogue of Granisetron (G780000), a specific serotonin (5HT3) receptor antagonist. Used as an antiemetic.
    References Kilpatrick, G.J., et al.: Nature, 330, 746 (1987); Durig, T., et al.: J. Pharm. Sci., 86, 1092 (1997); Yuasa, H., et al.: Chem. Pharm. Bull., 44, 1361 (1996)

    Formule :C18D3H21N4O
    Couleur et forme :Neat
    Masse moléculaire :315.43

    Ref: TR-G780003

    25mg
    1.811,00€
    2500µg
    265,00€
  • 1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide

    Produit contrôlé
    CAS :
    1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide is a potent protein kinase inhibitor with anticancer properties. It has been shown to inhibit the growth of cancer cells by blocking the cell cycle and inducing apoptosis. This medicinal compound has been found to be effective in inhibiting various human kinases, including those involved in tumor growth and proliferation. In Chinese hamster ovary cells, this inhibitor has been shown to have a strong effect on the phosphorylation of key proteins involved in cell signaling pathways. The compound also exhibits selectivity towards specific kinases, making it a promising candidate for targeted cancer therapies. Overall, 1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-
    Formule :C18H24N4O
    Degré de pureté :Min. 95%
    Masse moléculaire :315.4 g/mol

    Ref: 3D-ZYB92576

    25mg
    1.280,00€
    50mg
    1.780,00€